FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Whitehouse

Research Profile

Disorders

Anatomy

Concepts & Ideas

Geographic Areas

United States

Chemicals & Drugs

Procedures

Clinical Trials as Topic

Activities & Behaviors

Activities of Daily Living

Co-author Network

Publications

TOP 3
Daniel R George; Sara H Qualls; Cameron J Camp; Peter J Whitehouse
Renovating Alzheimer's: "Constructive" Reflections on the New Clinical and Research Diagnostic Guidelines.
Daniel R George; Peter J Whitehouse; Dave Harris
"Occupy nature": passing activism across generations.
Daniel R George; Peter J Whitehouse
Marketplace of memory: what the brain fitness technology industry says about us and how we can do better.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Whitehouse (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Daniel R George; Sara H Qualls; Cameron J Camp; Peter J Whitehouse
Renovating Alzheimer's: "Constructive" Reflections on the New Clinical and Research Diagnostic Guidelines.
The Gerontologist 2013;53(3):378-87.
2012: Daniel R George; Peter J Whitehouse; Dave Harris
"Occupy nature": passing activism across generations.
Journal of the American Geriatrics Society 2012;60(9):1770-1.
2011: Daniel R George; Peter J Whitehouse
Marketplace of memory: what the brain fitness technology industry says about us and how we can do better.
The Gerontologist 2011;51(5):590-6.
2011: Daniel R George; Peter J Whitehouse; Jesse Ballenger
The evolving classification of dementia: placing the DSM-V in a meaningful historical and cultural context and pondering the future of "Alzheimer's".
Culture, medicine and psychiatry 2011;35(3):417-35.
2011: Peter J Whitehouse
Empowering whom? Neuroethics at its limits.
Lancet 2011;377(9764):468.
2011: Peter J Whitehouse; Daniel R George
Uncertain progress on the fuzzy boundaries of Alzheimer's disease: reading between the guidelines.
Journal of Alzheimer's disease : JAD 2011;26(1):1-5.
2011: Peter J Whitehouse; Daniel R George; Simon D'Alton
Describing the dying days of "Alzheimer's disease".
Journal of Alzheimer's disease : JAD 2011;24(1):11-3.
2010: Alan D Dangour; Elizabeth Allen; Marcus Richards; Peter J Whitehouse; Ricardo Uauy
Design considerations in long-term intervention studies for the prevention of cognitive decline or dementia.
Nutrition reviews 2010;68 Suppl 1():S16-21.
2010: Serena E P Vayda; Marian B Patterson; Peter J Whitehouse
The future of dementia: a case of hardening of the categories.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2010;18(9):755-8.
2010: Daniel R George; Peter J Whitehouse
Intergenerational volunteering and quality of life for persons with mild-to-moderate dementia: results from a 5-month intervention study in the United States.
Journal of the American Geriatrics Society 2010;58(4):796-7.
2010: Alan D Dangour; Peter J Whitehouse; Kevin Rafferty; Stephen A Mitchell; Lesley Smith; Sophie Hawkesworth; Bruno Vellas
B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review.
Journal of Alzheimer's disease : JAD 2010;22(1):205-24.
2010: Peter J Whitehouse; Daniel George
Protecting life and lives: putting gene research in context.
Journal of Alzheimer's disease : JAD 2010;20(2):415-6.
2009: MAJID FOTUHI; vladimir hachinski; Peter J Whitehouse
Changing perspectives regarding late-life dementia.
Nature reviews. Neurology 2009;5(12):649-58.
2009: MAJID FOTUHI; vladimir hachinski; Miia Kivipelto; Peter J Whitehouse
Factors associated with resistance to dementia despite high Alzheimer disease pathology.
Neurology 2009;73(19):1607; author reply 1607-8.
2009: D R George; A D Dangour; L Smith; J Ruddick; Bruno Vellas; Peter J Whitehouse
The role of nutrients in the prevention and treatment of Alzheimer's disease: methodology for a systematic review.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16 Suppl 1():8-11.
2009: Robert C Green; J Scott Roberts; L Adrienne Cupples; Norman Richard Relkin; Peter J Whitehouse; Tamsen Brown; Susan LaRusse Eckert; Melissa Butson; A Dessa Sadovnick; Kimberly Quaid; Clara Chen; Robert Cook-Deegan; Lindsay A Farrer
Disclosure of APOE genotype for risk of Alzheimer's disease.
The New England journal of medicine 2009;361(3):245-54.
2009: Peter J Whitehouse; Daniel George
Banking on stories for healthier cognitive ageing.
Lancet 2009;373(9670):1166-7.
2008: Carol B Stocking; Gavin W Hougham; Deborah D Danner; Marian B Patterson; Peter J Whitehouse; Greg A. Sachs
Variable judgments of decisional capacity in cognitively impaired research subjects.
Journal of the American Geriatrics Society 2008;56(10):1893-7.
2008: Peter J Whitehouse
National Institute of Health and Clinical Excellence decision processes supported by UK High Court: the debate about the value of Alzheimer's disease drugs continues.
Journal of Alzheimer's disease : JAD 2008;13(3):239-40.
2008: Neal V Dawson; Mendel E Singer; Leslie Lenert; Marian B Patterson; Susie A Sami; Iahn Gonsenhouser; Heather A Lindstrom; Kathleen Smyth; Melissa J Barber; Peter J Whitehouse
Health state valuation in mild to moderate cognitive impairment: feasibility of computer-based, direct patient utility assessment.
Medical decision making : an international journal of the Society for Medical Decision Making 2008;28(2):220-32.
2008: Kurt D Christensen; J Scott Roberts; Charmaine D M Royal; Grace-Ann Fasaye; Thomas Obisesan; L Adrienne Cupples; Peter J Whitehouse; Melissa Barber Butson; Erin Linnenbringer; Norman Richard Relkin; Lindsay A Farrer; Robert Cook-Deegan; Robert C Green
Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.
Genetics in medicine : official journal of the American College of Medical Genetics 2008;10(3):207-14.
2008: Peter J Whitehouse
Why I no longer consult for drug companies.
Culture, medicine and psychiatry 2008;32(1):4-10.
2008: Kellie H Campbell; Carol B Stocking; Gavin W Hougham; Peter J Whitehouse; Deborah D Danner; Greg A. Sachs
Dementia, diagnostic disclosure, and self-reported health status.
Journal of the American Geriatrics Society 2008;56(2):296-300.
2008: Peter J Whitehouse; Susie A Sami
Quality of life in dementias.
Handbook of clinical neurology 2008;89():97-100.
2007: Carol B Stocking; Gavin W Hougham; Deborah D Danner; Marian B Patterson; Peter J Whitehouse; Greg A. Sachs
Empirical assessment of a research advance directive for persons with dementia and their proxies.
Journal of the American Geriatrics Society 2007;55(10):1609-12.
2007: Peter J Whitehouse; Sara Waller
Involuntary emotional expressive disorder: a case for a deeper neuroethics.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2007;4(3):560-7.
2007: Peter J Whitehouse
Commentary: integrative narrative evolutionary health: toward a wiser view of Alzheimer's disease.
Journal of alternative and complementary medicine (New York, N.Y.) 2007;13(3):341-4.
2007: Peter J Whitehouse
Mild cognitive impairment--a confused concept?
Nature clinical practice. Neurology 2007;3(2):62-3.
2006: Susan LaRusse Eckert; Heather L Katzen; J Scott Roberts; Melissa Barber; Lisa D Ravdin; Norman Richard Relkin; Peter J Whitehouse; Robert C Green
Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study.
Genetics in medicine : official journal of the American College of Medical Genetics 2006;8(12):746-51.
2006: Peter J Whitehouse; Julia L Rajcan; Susie A Sami; Marian B Patterson; Kathleen Smyth; Steven D Edland; Daniel R George
ADCS Prevention Instrument Project: pilot testing of a book club as a psychosocial intervention and recruitment and retention strategy.
Alzheimer disease and associated disorders 2006;20(4 Suppl 3):S203-8.
2006: Mary Sano; Carolyn W Zhu; Peter J Whitehouse; Steven D Edland; Shelia Jin; Karin Ernstrom; Ronald Thomas; Leon J Thal; Steven H Ferris
ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly.
Alzheimer disease and associated disorders 2006;20(4 Suppl 3):S191-202.
2006: Marian B Patterson; Peter J Whitehouse; Steven D Edland; Susie A Sami; Mary Sano; Kathleen Smyth; Myron Weiner
ADCS Prevention Instrument Project: quality of life assessment (QOL).
Alzheimer disease and associated disorders 2006;20(4 Suppl 3):S179-90.
2006: Steven H Ferris; Paul S Aisen; Jeffrey L Cummings; Douglas Galasko; David P Salmon; Lon S Schneider; Mary Sano; Peter J Whitehouse; Steven D Edland; Leon J Thal
ADCS Prevention Instrument Project: overview and initial results.
Alzheimer disease and associated disorders 2006;20(4 Suppl 3):S109-23.
2006: Peter J Whitehouse
The end of AD. Part 3.
Alzheimer disease and associated disorders 2006;20(4):195-8.
2006: Peter J Whitehouse; Henry Brodaty
Mild cognitive impairment.
Lancet 2006;367(9527):1979.
2006: Carol B Stocking; Gavin W Hougham; Deborah D Danner; Marian B Patterson; Peter J Whitehouse; Greg A. Sachs
Speaking of research advance directives: planning for future research participation.
Neurology 2006;66(9):1361-6.
2006: S Gauthier; Barry Reisberg; Michael Zaudig; Ronald C. Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David A Bennett; Howard Chertkow; Jeffrey L Cummings; Mony J de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip scheltens; Mary C Tierney; Peter J Whitehouse; Bengt Winblad
Mild cognitive impairment.
Lancet 2006;367(9518):1262-70.
2006: Peter J Whitehouse
Quality of life: the bridge from the cholinergic basal forebrain to cognitive science and bioethics.
Journal of Alzheimer's disease : JAD 2006;9(3 Suppl):447-53.
2005: J Scott Roberts; L Adrienne Cupples; Norman Richard Relkin; Peter J Whitehouse; Robert C Green
Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.
Journal of geriatric psychiatry and neurology 2005;18(4):250-5.
2005: Peter J Whitehouse; Eric T Juengst
Antiaging medicine and mild cognitive impairment: practice and policy issues for geriatrics.
Journal of the American Geriatrics Society 2005;53(8):1417-22.
2005: Peter J Whitehouse; Atwood D Gaines; Heather Lindstrom; Janice E Graham
Anthropological contributions to the understanding of age-related cognitive impairment.
Lancet neurology 2005;4(5):320-6.
2005: Susan LaRusse; J Scott Roberts; Theresa M Marteau; Heather L Katzen; Erin L Linnenbringer; Melissa Barber; Peter J Whitehouse; Kimberly Quaid; Tamsen Brown; Robert C Green; Norman Richard Relkin
Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer disease.
Genetics in medicine : official journal of the American College of Medical Genetics 2005;7(1):48-53.
2004: Peter J Whitehouse
Regulatory aspects of mild cognitive impairment: toward a harmonized perspective.
Dialogues in clinical neuroscience 2004;6(4):409-14.
2004: Jason H T Karlawish; Peter J Whitehouse; Rupert H McShane
Silence science: the problem of not reporting negative trials.
Alzheimer disease and associated disorders 2004;18(4):180-2.
2004: J Scott Roberts; Melissa Barber; Tamsen M Brown; L Adrienne Cupples; Lindsay A Farrer; Susan LaRusse; Stephen G Post; Kimberly Quaid; Lisa D Ravdin; Norman Richard Relkin; A Dessa Sadovnick; Peter J Whitehouse; John L Woodard; Robert C Green
Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial.
Genetics in medicine : official journal of the American College of Medical Genetics 2004;6(4):197-203.
2004: L Adrienne Cupples; Lindsay A Farrer; A Dessa Sadovnick; Norman Richard Relkin; Peter J Whitehouse; Robert C Green
Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study.
Genetics in medicine : official journal of the American College of Medical Genetics 2004;6(4):192-6.
2004: Maxwell J Mehlman; Robert H Binstock; Eric T Juengst; Roselle S Ponsaran; Peter J Whitehouse
Anti-aging medicine: can consumers be better protected?
The Gerontologist 2004;44(3):304-10.
2004: Peter J Whitehouse; Giovanni B Frisoni; Stephen Post
Breaking the diagnosis of dementia.
Lancet neurology 2004;3(2):124-8.
2004: Jung H Lee; Robert P Friedland; Peter J Whitehouse; Jong Inn Woo
Twenty-four-hour rhythms of sleep-wake cycle and temperature in Alzheimer's disease.
The Journal of neuropsychiatry and clinical neurosciences 2004;16(2):192-8.
2004: Peter J Whitehouse; Jennifer R Fishman
Justice and the house of medicine: the mortgaging of ecology and economics.
The American journal of bioethics : AJOB 2004;4(2):43-5.
2004: Peter J Whitehouse
Paying attention to acetylcholine: the key to wisdom and quality of life?
Progress in brain research 2004;145():311-7.
2003: Peter J Whitehouse; Marian B Patterson; Susie A Sami
Quality of life in dementia: ten years later.
Alzheimer disease and associated disorders 2003;17(4):199-200.
2003: Gavin W Hougham; Greg A. Sachs; Deborah D Danner; Jim Mintz; Marian Patterson; Laura W Roberts; Laura A Siminoff; Jeremy Sugarman; Peter J Whitehouse; Donna A Wirshing
Empirical research on informed consent with the cognitively impaired.
IRB 2003;Suppl 25(5):S26-S32.
2003: Peter J Whitehouse
MSJAMA: Lessons and responses in Alzheimer disease research.
JAMA : the journal of the American Medical Association 2003;290(1):115.
2003: Eric T Juengst; Robert H Binstock; Maxwell J Mehlman; Stephen G Post; Peter J Whitehouse
Biogerontology, "anti-aging medicine," and the challenges of human enhancement.
The Hastings Center report 2003;33(4):21-30.
2003: Peter J Whitehouse
Classification of the dementias.
Lancet 2003;361(9364):1227.
2003: Peter J Whitehouse
Research advances in the neurology of dementia.
Alzheimer disease and associated disorders 2003;17(2):127-8.
2003: J Scott Roberts; Susan LaRusse; Heather L Katzen; Peter J Whitehouse; Melissa Barber; Stephen G Post; Norman Richard Relkin; Kimberly Quaid; Robert H Pietrzak; L Adrienne Cupples; Lindsay A Farrer; Tamsen Brown; Robert C Green
Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease.
Alzheimer disease and associated disorders 2003;17(2):86-93.
2003: Peter J Whitehouse
Regulatory perspectives: one academic viewpoint from the United States.
International psychogeriatrics / IPA 2003;15 Suppl 1():277-81.
2003: Peter J Whitehouse
The rebirth of bioethics: extending the original formulations of Van Rensselaer Potter.
The American journal of bioethics : AJOB 2003;3(4):W26-W31.
2003: Szabolcs Szatmári; Peter J Whitehouse
Vinpocetine for cognitive impairment and dementia.
Cochrane database of systematic reviews (Online) 2003;(1):CD003119.
2002: Jason H T Karlawish; David S. Knopman; Christopher M Clark; John C Morris; Daniel C Marson; Peter J Whitehouse; Claudia H Kawas
Informed consent for Alzheimer's disease clinical trials: a survey of clinical investigators.
IRB 2002;24(5):1-5.
2002: Jerome A Yesavage; Martin S Mumenthaler; Joy L Taylor; Leah Friedman; Ruth O'Hara; Javaid I Sheikh; Jared R Tinklenberg; Peter J Whitehouse
Donepezil and flight simulator performance: effects on retention of complex skills.
Neurology 2002;59(1):123-5.
2002: Melissa Barber; Peter J Whitehouse
Susceptibility testing for Alzheimer's disease: race for the future.
Lancet neurology 2002;1(1):10.
2002: Peter J Whitehouse
Van Rensselaer Potter: an intellectual memoir.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees 2002;11(4):331-4.
2002: Peter J Whitehouse
The evolution of gene patenting.
The American journal of bioethics : AJOB 2002;2(3):23-4.
2001: Peter J Whitehouse
The new age of anti-terrorism.
The Gerontologist 2001;41(6):831-2.
2001: Peter J Whitehouse
The end of Alzheimer disease II: commentary on "Decisions to treat or not to treat pneumonia in demented psychogeriatric nursing home patients".
Alzheimer disease and associated disorders 2001;15(3):118.
2001: Rachelle S Doody; J C Stevens; C Beck; R M Dubinsky; Jeffrey A Kaye; L Gwyther; Richard C Mohs; Leon J Thal; Peter J Whitehouse; Steven T DeKosky; Jeffrey L Cummings
Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.
Neurology 2001;56(9):1154-66.
2001: James L Mack; Peter J Whitehouse
Quality of Life in Dementia: state of the art--report of the International Working Group for Harmonization of Dementia Drug Guidelines and the Alzheimer's Society satellite meeting.
Alzheimer disease and associated disorders 2001;15(2):69-71.
2001: Peter J Whitehouse
The end of Alzheimer disease.
Alzheimer disease and associated disorders 2001;15(2):59-62.
2001: Stephen G Post; J C Stuckey; Peter J Whitehouse; S Ollerton; C Durkin; D Robbins; S J Fallcreek
A focus group on cognition-enhancing medications in Alzheimer disease: disparities between professionals and consumers.
Alzheimer disease and associated disorders 2001;15(2):80-8.
2000: Linda Teri; Rebecca G Logsdon; Elaine Peskind; Murray A Raskind; Myron Weiner; Rochelle E Tractenberg; Norman L Foster; Lon S Schneider; Mary Sano; Peter J Whitehouse; Pierre N. Tariot; Alan M Mellow; A P Auchus; Michael Grundman; Ronald Thomas; Kimberly Schafer; Leon J Thal
Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.
Neurology 2000;55(9):1271-8.
2000: Linus Jönsson; Bengt Jönsson; Anders Wimo; Peter J Whitehouse; Bengt Winblad
Second International Pharmacoeconomic Conference on Alzheimer' s Disease.
Alzheimer disease and associated disorders 2000;14(3):137-40.
2000: Peter J Whitehouse
New models for a new age.
Alzheimer disease and associated disorders 2000;14(2):59.
2000: Peter J Whitehouse
Harmonization of Dementia Drug Guidelines (United States and Europe): a report of the International Working Group for the Harmonization for Dementia Drug Guidelines.
Alzheimer disease and associated disorders 2000;14 Suppl 1():S119-22.
1999: K A Jobst; D Shostak; Peter J Whitehouse
Diseases of meaning, manifestations of health, and metaphor.
Journal of alternative and complementary medicine (New York, N.Y.) 1999;5(6):495-502.
1999: S Gauthier; kenneth rockwood; I Gélinas; L Sykes; S Teunisse; JM Orgogozo; Timo Erkinjuntti; H Erzigkeit; M Gleeson; B Kittner; M Pontecorvo; H Feldman; Peter J Whitehouse
Outcome measures for the study of activities of daily living in vascular dementia.
Alzheimer disease and associated disorders 1999;13 Suppl 3():S143-7.
1999: Timo Erkinjuntti; T Sawada; Peter J Whitehouse
The Osaka Conference on Vascular Dementia 1998.
Alzheimer disease and associated disorders 1999;13 Suppl 3():S1-3.
1999: S W Hinze; Atwood D Gaines; A J Lerner; Peter J Whitehouse
An interdisciplinary response to the Reagan Research Institute Report on Women and Alzheimer's Disease.
Alzheimer disease and associated disorders 1999;13(4):183-6.
1999: J F Ballenger; J L Nelson; Peter J Whitehouse
Beyond "progress" in the history of Alzheimer disease.
Alzheimer disease and associated disorders 1999;13(3):130-1.
1999: Claudia H Kawas; C M Clark; Martin R Farlow; David S. Knopman; Daniel C Marson; John C Morris; Leon J Thal; Peter J Whitehouse
Clinical trials in Alzheimer disease: debate on the use of placebo controls.
Alzheimer disease and associated disorders 1999;13(3):124-9.
1999: Peter J Whitehouse; Raul Arizaga; H Brodaty; S Gauthier; N Graham; R C Green; A Homma; C Mangone; V Senanarong; X H Xu
Placebos in clinical trials in Alzheimer disease: an international discussion.
Alzheimer disease and associated disorders 1999;13(3):121-3.
1999: Peter J Whitehouse
Interesting conflicts and conflicting interests.
Journal of the American Geriatrics Society 1999;47(6):759-61.
1999: H Brodaty; R Dresser; M Eisner; T Erkunjuntti; S Gauthier; N Graham; C Jonker; Greg A. Sachs; Peter J Whitehouse
Alzheimer's Disease International and International Working Group for Harmonization of Dementia Drug Guidelines for research involving human subjects with dementia.
Alzheimer disease and associated disorders 1999;13(2):71-9.
1999: Carole A Cohen; Peter J Whitehouse; Stephen G Post; S Gauthier; A Eberhart; L LeDuc
Ethical issues in Alzheimer disease: the experience of a national Alzheimer society task force.
Alzheimer disease and associated disorders 1999;13(2):66-70.
1999: Stephen G Post; Peter J Whitehouse; J L Nelson; Greg A. Sachs
Alzheimer disease ethics: a continuing area of public interest.
Alzheimer disease and associated disorders 1999;13(2):63-5.
1999: Peter J Whitehouse
Managed care and complementary and alternative medicine: lessons from the past and suggestions for the future.
Journal of alternative and complementary medicine (New York, N.Y.) 1999;5(1):1-2.
1999: Peter J Whitehouse
Alzheimer's disease: past, present, and future.
European archives of psychiatry and clinical neuroscience 1999;249 Suppl 3():43-5.
1999: Stephen G Post; Peter J Whitehouse
Spirituality, religion, and Alzheimer's disease.
Journal of health care chaplaincy 1999;8(1-2):45-57.
1999: Peter J Whitehouse
The ecomedical disconnection syndrome.
The Hastings Center report 1999;29(1):41-4.
1998: Atwood D Gaines; Peter J Whitehouse
Harmony and consensus: cultural aspects of organization in international science.
Alzheimer disease and associated disorders 1998;12(4):295-301.
1998: Peter J Whitehouse; B Kittner; M Roessner; Martin N Rossor; Mary Sano; Leon J Thal; Bengt Winblad
Clinical trial designs for demonstrating disease-course-altering effects in dementia.
Alzheimer disease and associated disorders 1998;12(4):281-94.
1998: Peter J Whitehouse; Bengt Winblad; D Shostak; A Bhattacharjya; M Brod; H Brodaty; Avi Dor; Howard Feldman; F Forette; S Gauthier; J Hay; C Henke; S Hill; Vera Mastey; P Neumann; B O'Brien; K Pugner; Mary Sano; T Sawada; R Stone; Anders Wimo
First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary.
Alzheimer disease and associated disorders 1998;12(4):266-80.
1998: Rachelle S Doody; Peter J Whitehouse; Q Chen; L Wang; Q Wu; M Rosser; X H Xu
Alzheimer disease-related activities in China: a report from the International Working Group on the Harmonization of Dementia Drug Guidelines.
Alzheimer disease and associated disorders 1998;12(4):263-5.
1998: R J Harvey; Peter J Whitehouse; Martin N Rossor
Report of the European Working Group on Dementia Drug Guidelines Meeting--Brussels, November 1997.
Alzheimer disease and associated disorders 1998;12(4):259-61.
1998: Myron Weiner; Elizabeth Koss; M Patterson; Shelia Jin; Linda Teri; Ron Thomas; Leon J Thal; Peter J Whitehouse
A comparison of the Cohen-Mansfield agitation inventory with the CERAD behavioral rating scale for dementia in community-dwelling persons with Alzheimer's disease.
Journal of psychiatric research 1998;32(6):347-51.
1998: Jason H T Karlawish; Peter J Whitehouse
Is the placebo control obsolete in a world after donepezil and vitamin E?
Archives of neurology 1998;55(11):1420-4.
1998: Stephen G Post; Peter J Whitehouse
Emerging antidementia drugs: a preliminary ethical view.
Journal of the American Geriatrics Society 1998;46(6):784-7.
1998: Peter J Whitehouse
Donepezil.
Drugs of today (Barcelona, Spain : 1998) 1998;34(4):321-6.
1998: A L Smith; Peter J Whitehouse
Progress in the management of Alzheimer's disease.
Hospital practice (1995) 1998;33(3):151-4, 157-66.
1998: Yoshihisa Kitamura; Shun Shimohama; W Kamoshima; T Ota; Yasuji Matsuoka; Yasuyuki Nomura; Mark A. Smith; George Perry; Peter J Whitehouse; Tadatsugu Taniguchi
Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease.
Brain research 1998;780(2):260-9.
1998: Peter J Whitehouse
The cholinergic deficit in Alzheimer's disease.
The Journal of clinical psychiatry 1998;59 Suppl 13():19-22.
1997: J W Hay; Mary Sano; Peter J Whitehouse
The costs and social burdens of Alzheimer disease: what can and should be done?
Alzheimer disease and associated disorders 1997;11(4):181-3.
1997: Geldmacher David; A J Lerner; J M Voci; E A Noelker; L C Somple; Peter J Whitehouse
Treatment of functional decline in adults with Down syndrome using selective serotonin-reuptake inhibitor drugs.
Journal of geriatric psychiatry and neurology 1997;10(3):99-104.
1997: Ashwini R Sehgal; Scott F Grey; Peter B Deoreo; Peter J Whitehouse
Prevalence, recognition, and implications of mental impairment among hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;30(1):41-9.
1997: Peter J Whitehouse; F Reidenbach
Guidelines for early identification of Alzheimer Disease.
Alzheimer disease and associated disorders 1997;11(2):61-2.
1997: Peter J Whitehouse; Eric T Juengst; Maxwell J Mehlman; Thomas H Murray
Enhancing cognition in the intellectually intact.
The Hastings Center report 1997;27(3):14-22.
1997: Peter J Whitehouse
Genesis of Alzheimer's disease.
Neurology 1997;48(5 Suppl 7):S2-7.
1997: Geldmacher David; Peter J Whitehouse
Differential diagnosis of Alzheimer's disease.
Neurology 1997;48(5 Suppl 6):S2-9.
1997: R Dresser; Peter J Whitehouse
Emergency research and research involving subjects with cognitive impairment: ethical connections and contrasts.
Journal of the American Geriatrics Society 1997;45(4):521-3.
1997: Stephen G Post; Peter J Whitehouse; Robert H Binstock; Thomas D Bird; S K Eckert; Lindsay A Farrer; L M Fleck; Atwood D Gaines; Eric T Juengst; H Karlinsky; S Miles; Thomas H Murray; Kimberly Quaid; Norman Richard Relkin; Allen D Roses; Peter St George-Hyslop; Greg A. Sachs; B Steinbock; E F Truschke; A B Zinn
The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective.
JAMA : the journal of the American Medical Association 1997;277(10):832-6.
1997: Peter J Whitehouse
Readdressing our moral relationship to nonhuman creatures: commentary on "A dialogue on species-specific rights: humans and animals in bioethics.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees 1997;6(4):445-8.
1997: K Maslow; Peter J Whitehouse
Defining and measuring outcomes in Alzheimer disease research: conference findings.
Alzheimer disease and associated disorders 1997;11 Suppl 6():186-95.
1997: Kathleen Smyth; Steven H Ferris; P Fox; A Heyman; Douglas Holmes; J N Morris; C D Phillips; Richard Schulz; J Teresi; Peter J Whitehouse
Measurement choices in multi-site studies of outcomes in dementia.
Alzheimer disease and associated disorders 1997;11 Suppl 6():30-44.
1997: Peter J Whitehouse; K Maslow
Defining and measuring outcomes in Alzheimer disease research: introduction and overview.
Alzheimer disease and associated disorders 1997;11 Suppl 6():1-6.
1997: Peter J Whitehouse
Pharmacoeconomics of dementia.
Alzheimer disease and associated disorders 1997;11 Suppl 5():S22-32; discussion S32-3.
1997: Peter J Whitehouse; JM Orgogozo; R E Becker; S Gauthier; M Pontecorvo; H Erzigkeit; S Rogers; Richard C Mohs; N Bodick; G Bruno; P Dal-Bianco
Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer disease and associated disorders 1997;11 Suppl 3():56-60.
1997: N Bodick; F Forette; D Hadler; R J Harvey; P Leber; Ian G McKeith; PJ Riekkinen; Martin N Rossor; Philip scheltens; S Shimohama; R Spiegel; S Tanaka; Leon J Thal; Y Urata; Peter J Whitehouse; Gordon K Wilcock
Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group.
Alzheimer disease and associated disorders 1997;11 Suppl 3():50-3.
1997: R J Harvey; C G Sciulli; R M Mason; Peter J Whitehouse
Information technology and the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer disease and associated disorders 1997;11 Suppl 3():29-32.
1997: Stephen G Post; B Beerman; H Brodaty; A W Gaines; S Gauthier; Geldmacher David; S Hill; A Homma; Martin N Rossor; Peter J Whitehouse; Bengt Winblad
Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer disease and associated disorders 1997;11 Suppl 3():26-8.
1997: Peter J Whitehouse
The International Working Group on Harmonization of Dementia Drug Guidelines: past, present, and future.
Alzheimer disease and associated disorders 1997;11 Suppl 3():2-5.
1997: Joan A Mackell; Steven H Ferris; Richard C Mohs; Lon S Schneider; Douglas Galasko; Peter J Whitehouse; F Schmitt; Mary Sano; Leon J Thal
Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study.
Alzheimer disease and associated disorders 1997;11 Suppl 2():S65-9.
1997: Elizabeth Koss; Myron Weiner; C Ernesto; Jiska Cohen-Mansfield; Steven H Ferris; Michael Grundman; Kimberly Schafer; Mary Sano; Leon J Thal; Ron Thomas; Peter J Whitehouse
Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study.
Alzheimer disease and associated disorders 1997;11 Suppl 2():S45-50.
1997: Marian B Patterson; James L Mack; Joan A Mackell; Ron Thomas; Pierre N. Tariot; Myron Weiner; Peter J Whitehouse
A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. The Alzheimer's Disease Cooperative Study.
Alzheimer disease and associated disorders 1997;11 Suppl 2():S40-4.
1997: Steven H Ferris; Joan A Mackell; Richard C Mohs; Lon S Schneider; Douglas Galasko; Peter J Whitehouse; Frederick A Schmitt; Mary Sano; Ronald Thomas; C Ernesto; Michael Grundman; Kimberly Schafer; Leon J Thal
A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study.
Alzheimer disease and associated disorders 1997;11 Suppl 2():S1-12.
1997: Peter J Whitehouse; C G Sciulli; R M Mason
Dementia drug development: use of information systems to harmonize global drug development.
Psychopharmacology bulletin 1997;33(1):129-33.
1997: Alistair Burns; Peter J Whitehouse; Thomas Arendt; H Försti
Alzheimer's disease in senile dementia: loss of neurones in the basal forebrain. Whitehouse, P., Price, D., Struble, R., Clarke, A., Coyle, J. and Delong, M. Science (1982), 215, 1237-1239.
International journal of geriatric psychiatry 1997;12(1):7-10.
1996: Eric Kodish; Thomas H Murray; Peter J Whitehouse
Conflict of interest in university-industry research relationships: realities, politics, and values.
Academic medicine : journal of the Association of American Medical Colleges 1996;71(12):1287-90.
1996: Geldmacher David; Peter J Whitehouse
Evaluation of dementia.
The New England journal of medicine 1996;335(5):330-6.
1996: M J Mehlman; Eric Kodish; Peter J Whitehouse; A B Zinn; S Sollitto; J Berger; E J Chiao; M S Dosick; Suzanne B Cassidy
The need for anonymous genetic counseling and testing.
American journal of human genetics 1996;58(2):393-7.
1996: Peter J Whitehouse; Marian B Patterson; Milton E Strauss; Geldmacher David; James L Mack; G C Gilmore; Elizabeth Koss
Hallucinations.
International psychogeriatrics / IPA 1996;8 Suppl 3():387-92.
1996: Myron Weiner; Elizabeth Koss; Katherine Wild; D G Folks; Pierre N. Tariot; H Luszczynska; Peter J Whitehouse
Measures of psychiatric symptoms in Alzheimer patients: a review.
Alzheimer disease and associated disorders 1996;10(1):20-30.
1996: Peter J Whitehouse; Stephen G Post; Greg A. Sachs
Dementia care at the end of life: empirical research and international collaboration.
Alzheimer disease and associated disorders 1996;10(1):3-4.
1996: Peter J Whitehouse; John C Morris
Disclosure of financial interest: a new policy for Alzheimer disease and associated disorders.
Alzheimer disease and associated disorders 1996;10(1):1-2.
1996: Peter J Whitehouse
Future prospects for Alzheimer's disease therapy: ethical and policy issues for the international community.
Acta neurologica Scandinavica. Supplementum 1996;165():145-9.
1996: Y Ku; Peter J Whitehouse
Complementary therapeutic alternatives: what can we learn?
Alzheimer disease and associated disorders 1996;10(2):61-2.
1995: Stephen G Post; Peter J Whitehouse
Fairhill guidelines on ethics of the care of people with Alzheimer's disease: a clinical summary. Center for Biomedical Ethics, Case Western Reserve University and the Alzheimer's Association.
Journal of the American Geriatrics Society 1995;43(12):1423-9.
1995: Shun Shimohama; Shimpei Fujimoto; M Chachin; Tadatsugu Taniguchi; George Perry; Peter J Whitehouse; J Kimura
Alterations of low molecular weight acid phosphatase protein level in Alzheimer's disease.
Brain research 1995;699(1):125-9.
1995: Peter J Whitehouse; W E Deal
Situated beyond modernity: lessons for Alzheimer's disease research.
Journal of the American Geriatrics Society 1995;43(11):1314-5.
1995: Peter J Whitehouse; J Voci
Therapeutic trials in Alzheimer's disease.
Current opinion in neurology 1995;8(4):275-8.
1995: Shun Shimohama; Shimpei Fujimoto; H Matsushima; T Takenawa; Tadatsugu Taniguchi; George Perry; Peter J Whitehouse; J Kimura
Alteration of phospholipase C-delta protein level and specific activity in Alzheimer's disease.
Journal of neurochemistry 1995;64(6):2629-34.
1995: D N Ripich; Stephen A Petrill; Peter J Whitehouse; E W Ziol
Gender differences in language of AD patients: a longitudinal study.
Neurology 1995;45(2):299-302.
1995: G C Gilmore; Peter J Whitehouse
Contrast sensitivity in Alzheimer's disease: a 1-year longitudinal analysis.
Optometry and vision science : official publication of the American Academy of Optometry 1995;72(2):83-91.
1995: Shun Shimohama; George Perry; P Richey; D Praprotnik; T Takenawa; K Fukami; Peter J Whitehouse; J Kimura
Characterization of the association of phospholipase C-delta with Alzheimer neurofibrillary tangles.
Brain research 1995;669(2):217-24.
1995: Peter J Whitehouse; Rajesh N. Kalaria
Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications.
Alzheimer disease and associated disorders 1995;9 Suppl 2():3-5.
1995: Peter J Whitehouse
Should we differentiate subtypes of Alzheimer disease?
Alzheimer disease and associated disorders 1995;9 Suppl 1():S1.
1994: Raymond Ownby; Elizabeth Koss; Kathleen Smyth; Peter J Whitehouse
The factor structure of the Brief Psychiatric Rating Scale in Alzheimer's disease.
Journal of geriatric psychiatry and neurology 1994;7(4):245-50.
1994: DJ Lanska; R D Currier; M Cohen; P Gambetti; E E Smith; J Bebin; J F Jackson; Peter J Whitehouse; William R Markesbery
Familial progressive subcortical gliosis.
Neurology 1994;44(9):1633-43.
1994: Rajesh N. Kalaria; P Homayoun; Peter J Whitehouse
Nicotinic cholinergic receptors associated with mammalian cerebral vessels.
Journal of the autonomic nervous system 1994;49 Suppl():S3-7.
1994: R Dresser; Peter J Whitehouse
The incompetent patient on the slippery slope.
The Hastings Center report 1994;24(4):6-12.
1994: Peter J Whitehouse; Geldmacher David
Pharmacotherapy for Alzheimer's disease.
Clinics in geriatric medicine 1994;10(2):339-50.
1994: Alan J Lerner; Elizabeth Koss; Marian B Patterson; Raymond Ownby; P Hedera; Robert P Friedland; Peter J Whitehouse
Concomitants of visual hallucinations in Alzheimer's disease.
Neurology 1994;44(3 Pt 1):523-7.
1994: Dallas M High; Peter J Whitehouse; Stephen G Post; Leonard Berg
Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper.
Alzheimer disease and associated disorders 1994;8(Suppl. 4):66-74.
1994: Stephen G Post; Danielle N Ripich; Peter J Whitehouse
Discourse ethics: research, dementia, and communication.
Alzheimer disease and associated disorders 1994;8(Suppl. 4):58-65.
1994: Dallas M High; Stephen G Post; Peter J Whitehouse
Introduction (to 6 articles and a position paper on ethical and legal issues in Alzheimer disease research)
Alzheimer disease and associated disorders 1994;8(Suppl. 4):1-4.
1994: Richard J Martin; Lisa P Gwyther; Peter J Whitehouse
Special care unit research: ethical issues.
Alzheimer disease and associated disorders 1994;8(Suppl. 1):S360-7.
1994: M B Patterson; Peter J Whitehouse
Behavioral symptoms in dementia: theories and therapies.
Alzheimer disease and associated disorders 1994;8 Suppl 3():1-3.
1994: D M High; Peter J Whitehouse; Stephen G Post; L Berg
Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper. National Institute on Aging.
Alzheimer disease and associated disorders 1994;8 Suppl 4():66-74.
1994: D M High; Stephen G Post; Peter J Whitehouse
Ethical and legal issues in Alzheimer disease research. Introduction.
Alzheimer disease and associated disorders 1994;8 Suppl 4():1-4.
1993: James L Mack; Marian B Patterson; Audrey H Schnell; Peter J Whitehouse
Performance of subjects with probable Alzheimer disease and normal elderly controls on the Gollin Incomplete Pictures Test.
Perceptual and motor skills 1993;77(3 Pt 1):951-69.
1993: Shun Shimohama; George Perry; P Richey; T Takenawa; Peter J Whitehouse; K Miyoshi; Toshihiko Suenaga; S Matsumoto; M Nishimura; J Kimura
Abnormal accumulation of phospholipase C-delta in filamentous inclusions of human neurodegenerative diseases.
Neuroscience letters 1993;162(1-2):183-6.
1993: Shun Shimohama; Shimpei Fujimoto; N Tresser; P Richey; George Perry; Peter J Whitehouse; Y Homma; T Takenawa; Tadatsugu Taniguchi; Toshihiko Suenaga
Aberrant phosphoinositide metabolism in Alzheimer's disease.
Annals of the New York Academy of Sciences 1993;695():46-9.
1993: J S Kennedy; M E Strauss; Kathleen Smyth; Peter J Whitehouse
The relationship of clinical psychopathologic rating and cognitive factors to clinical dementia staging.
Progress in neuro-psychopharmacology & biological psychiatry 1993;17(5):775-9.
1993: Peter J Whitehouse
Autopsy.
The Gerontologist 1993;33(4):436-7.
1993: Elizabeth Koss; Marian B Patterson; Raymond Ownby; J C Stuckey; Peter J Whitehouse
Memory evaluation in Alzheimer's disease. Caregivers' appraisals and objective testing.
Archives of neurology 1993;50(1):92-7.
1993: Peter J Whitehouse; Gary Landreth; Steven G Younkin
Molecular biology of Alzheimer's disease.
Molecular genetic medicine 1993;3():95-137.
1993: Peter J Whitehouse
Cholinergic therapy in dementia.
Acta neurologica Scandinavica. Supplementum 1993;149():42-5.
1992: Kenneth L Davis; Leon J Thal; E R Gamzu; C S Davis; Robert F Woolson; S I Gracon; David Drachman; Lon S Schneider; Peter J Whitehouse; T M Hoover
A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.
The New England journal of medicine 1992;327(18):1253-9.
1992: M Cohen; D Lanska; U Roessmann; B Karaman; E Ganz; Peter J Whitehouse; Pierluigi Gambetti
Amyloidoma of the CNS. I. Clinical and pathologic study.
Neurology 1992;42(10):2019-23.
1992: A Chatterjee; M E Strauss; Kathleen Smyth; Peter J Whitehouse
Personality changes in Alzheimer's disease.
Archives of neurology 1992;49(5):486-91.
1992: Stephen G Post; J R Botkin; Peter J Whitehouse
Selective abortion for familial Alzheimer disease?
Obstetrics and gynecology 1992;79(5 ( Pt 1)):794-8.
1992: Mario F Mendez; R J Martin; Kathleen Smyth; Peter J Whitehouse
Disturbances of person identification in Alzheimer's disease. A retrospective study.
The Journal of nervous and mental disease 1992;180(2):94-6.
1992: Stephen G Post; Peter J Whitehouse
Dementia and the life-prolonging technologies used: an ethical question.
Alzheimer disease and associated disorders 1992;6(1):3-6.
1992: Marian B Patterson; James L Mack; M M Neundorfer; R J Martin; Kathleen Smyth; Peter J Whitehouse
Assessment of functional ability in Alzheimer disease: a review and a preliminary report on the Cleveland Scale for Activities of Daily Living.
Alzheimer disease and associated disorders 1992;6(3):145-63.
1992: Peter J Whitehouse; Peter V Rabins
Quality of life and dementia.
Alzheimer disease and associated disorders 1992;6(3):135-7.
1992: Linda Teri; Peter V Rabins; Peter J Whitehouse; L Berg; Barry Reisberg; Trey Sunderland; B Eichelman; C Phelps
Management of behavior disturbance in Alzheimer disease: current knowledge and future directions.
Alzheimer disease and associated disorders 1992;6(2):77-88.
1992: M B Patterson; Peter J Whitehouse
Behavioral symptoms in Alzheimer disease: a look ahead.
Alzheimer disease and associated disorders 1992;6(2):71-2.
1992: Peter J Whitehouse
Alzheimer's disease: relationship of cognition and behavior to neurochemistry.
International psychogeriatrics / IPA 1992;4 Suppl 1():71-8.
1992: Alan J Lerner; Robert P Friedland; Peter J Whitehouse
Uses of biological markers.
Alzheimer disease and associated disorders 1992;6(4):197-200.
1991: John E Piletz; M Sarasua; Peter J Whitehouse; M Chotani
Intracellular membranes are more fluid in platelets of Alzheimer's disease patients.
Neurobiology of aging 1991;12(5):401-6.
1991: Peter J Whitehouse
Geriatric neurology.
Neurology 1991;41(8):1169-70.
1991: D N Ripich; D Vertes; Peter J Whitehouse; Scott A Fulton; B Ekelman
Turn-taking and speech act patterns in the discourse of senile dementia of the Alzheimer's type patients.
Brain and language 1991;40(3):330-43.
1991: Peter J Whitehouse
Pathology in the cholinergic basal forebrain: implications for treatment.
Advances in experimental medicine and biology 1991;295():447-52.
1991: Peter J Whitehouse
Treatment of Alzheimer disease.
Alzheimer disease and associated disorders 1991;5 Suppl 1():S32-6.
1990: M V Wagster; Peter J Whitehouse; Lary Walker; Kenneth J Kellar; Donald L Price
Laminar organization and age-related loss of cholinergic receptors in temporal neocortex of rhesus monkey.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1990;10(9):2879-85.
1990: Mario F Mendez; M A Mendez; R Martin; Kathleen Smyth; Peter J Whitehouse
Complex visual disturbances in Alzheimer's disease.
Neurology 1990;40(3 Pt 1):439-43.
1990: Marian B Patterson; Audrey H Schnell; R J Martin; Mario F Mendez; Kathleen Smyth; Peter J Whitehouse
Assessment of behavioral and affective symptoms in Alzheimer's disease.
Journal of geriatric psychiatry and neurology 1990;3(1):21-30.
1990: L F Jarvik; L Berg; raymond bartus; L Heston; N Leith; C Phelps; R Shader; Peter J Whitehouse
Clinical drug trials in Alzheimer disease. What are some of the issues?
Alzheimer disease and associated disorders 1990;4(4):193-202.
1990: Mario F Mendez; R J Martin; Kathleen Smyth; Peter J Whitehouse
Psychiatric symptoms associated with Alzheimer's disease.
The Journal of neuropsychiatry and clinical neurosciences 1990;2(1):28-33.
1990: M R Palmert; Marcia B Podlisny; todd golde; M L Cohen; Dora M. Kovacs; Rudolph E Tanzi; James Gusella; Peter J Whitehouse; D S Witker; Tilman Oltersdorf
Analysis of the beta-amyloid protein precursor of Alzheimer's disease: mRNAs and protein products.
Advances in neurology 1990;51():181-4.
1989: Evelyn L Teng; C Wimer; E Roberts; A R Damasio; P J Eslinger; MARSHAL FOLSTEIN; L E Tune; Peter J Whitehouse; E L Bardolph; H C Chui
Alzheimer's dementia: performance on parallel forms of the dementia assessment battery.
Journal of clinical and experimental neuropsychology 1989;11(6):899-912.
1989: Rajesh N. Kalaria; A C Andorn; Massimo Tabaton; Peter J Whitehouse; Sami I Harik; JR Unnerstall
Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus.
Journal of neurochemistry 1989;53(6):1772-81.
1989: J R Atack; Gary L Wenk; M V Wagster; Kenneth J Kellar; Peter J Whitehouse; Stanley I Rapoport
Bilateral changes in neocortical [3H]pirenzepine and [3H]oxotremorine-M binding following unilateral lesions of the rat nucleus basalis magnocellularis: an autoradiographic study.
Brain research 1989;483(2):367-72.
1989: R E Powers; S K Powell; C N Schlough; Peter J Whitehouse
Autopsy services for dementia patients.
The Gerontologist 1989;29(1):120-3.
1989: Peter J Whitehouse
Parkinson's disease and Alzheimer's disease: new neurochemical parallels.
Movement disorders : official journal of the Movement Disorder Society 1989;4 Suppl 1():S57-62.
1989: M Onorato; P Mulvihill; J Connolly; P Galloway; Peter J Whitehouse; George Perry
Alteration of neuritic cytoarchitecture in Alzheimer disease.
Progress in clinical and biological research 1989;317():781-9.
1989: R M Zweig; Christopher A Ross; J C Hedreen; Cynthia Steele; J E Cardillo; Peter J Whitehouse; MARSHAL FOLSTEIN; Donald L Price
Neuropathology of aminergic nuclei in Alzheimer's disease.
Progress in clinical and biological research 1989;317():353-65.
1989: Peter J Whitehouse; P Gambetti; Sami I Harik; Rajesh N. Kalaria; George Perry; S I Younkin; Massimo Tabaton; JR Unnerstall
Neurochemistry of dementia: establishing the links.
Progress in clinical and biological research 1989;317():131-42.
1989: M R Palmert; Marcia B Podlisny; todd golde; M L Cohen; Dora M. Kovacs; Rudolph E Tanzi; James Gusella; Peter J Whitehouse; D S Witker; Tilman Oltersdorf
The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives.
Progress in clinical and biological research 1989;317():971-84.
1988: Kathleen Smyth; Peter J Whitehouse; M Rust; J Kahana
Epidemiology, diagnosis, and management of Alzheimer's disease and related disorders: implications for minority populations.
Health matrix 1988;6(4):28-32.
1988: M F Casanova; R G Struble; Peter J Whitehouse; Donald L Price
A historical perspective on the neuropathology of dementia with emphasis on the senile plaque.
Boletín de la Asociación Médica de Puerto Rico 1988;80(11):424-8.
1988: Massimo Tabaton; Peter J Whitehouse; George Perry; Peter Davies; L Autilio-Gambetti; Pierluigi Gambetti
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy.
Annals of neurology 1988;24(3):407-13.
1988: Peter J Whitehouse
Specific neurochemical systems and memory.
Neurobiology of aging 1988;9(5-6):639-40.
1988: R M Zweig; Christopher A Ross; J C Hedreen; Cynthia Steele; J E Cardillo; Peter J Whitehouse; MARSHAL FOLSTEIN; Donald L Price
The neuropathology of aminergic nuclei in Alzheimer's disease.
Annals of neurology 1988;24(2):233-42.
1988: Peter J Whitehouse; A M Martino; K A Marcus; R M Zweig; Harvey S Singer; Donald L Price; Kenneth J Kellar
Reductions in acetylcholine and nicotine binding in several degenerative diseases.
Archives of neurology 1988;45(7):722-4.
1988: Peter J Whitehouse; A M Martino; M V Wagster; Donald L Price; Richard Mayeux; J R Atack; Kenneth J Kellar
Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study.
Neurology 1988;38(5):720-3.
1988: R M Zweig; J C Hedreen; W R Jankel; M F Casanova; Peter J Whitehouse; Donald L Price
Pathology in brainstem regions of individuals with primary dystonia.
Neurology 1988;38(5):702-6.
1988: Peter J Whitehouse
Intraventricular bethanechol in Alzheimer's disease: a continuing controversy.
Neurology 1988;38(2):307-8.
1988: J C Hedreen; R M Zweig; Mahlon R DeLong; Peter J Whitehouse; Donald L Price
Primary dystonias: a review of the pathology and suggestions for new directions of study.
Advances in neurology 1988;50():123-32.
1988: Peter J Whitehouse; JR Unnerstall
Neurochemistry of dementia.
European neurology 1988;28 Suppl 1():36-41.
1987: E B De Souza; Peter J Whitehouse; Susan E Folstein; Donald L Price; W W Vale
Corticotropin-releasing hormone (CRH) is decreased in the basal ganglia in Huntington's disease.
Brain research 1987;437(2):355-9.
1987: Kenneth J Kellar; Peter J Whitehouse; A M Martino-Barrows; K Marcus; Donald L Price
Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
Brain research 1987;436(1):62-8.
1987: JR Unnerstall; Peter J Whitehouse
New approaches to quantitative neuropathology: multivariate analysis of morphologic and neurochemical measures.
Neurobiology of aging 1987;8(6):567-9.
1987: Peter J Whitehouse
Reviewing the "breakthroughs" in Alzheimer's research.
Geriatrics 1987;42(9):107, 110-1.
1987: R J D'Amato; R M Zweig; Peter J Whitehouse; Gary L Wenk; Harvey S Singer; Richard Mayeux; Donald L Price; Solomon H Snyder
Aminergic systems in Alzheimer's disease and Parkinson's disease.
Annals of neurology 1987;22(2):229-36.
1987: R M Zweig; Peter J Whitehouse; M F Casanova; Lary Walker; W R Jankel; Donald L Price
Loss of pedunculopontine neurons in progressive supranuclear palsy.
Annals of neurology 1987;22(1):18-25.
1987: Gary S Wand; Conrad May; V May; Peter J Whitehouse; Stanley I Rapoport; B A Eipper
Alzheimer's disease: low levels of peptide alpha-amidation activity in brain and CSF.
Neurology 1987;37(6):1057-61.
1987: Peter J Whitehouse; W W Vale; R M Zweig; Harvey S Singer; Richard Mayeux; Michael J Kuhar; Donald L Price; E B De Souza
Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy.
Neurology 1987;37(6):905-9.
1987: R R Trifiletti; Adele M Snowman; Peter J Whitehouse; K A Marcus; Solomon H Snyder
Huntington's disease: increased number and altered regulation of benzodiazepine receptor complexes in frontal cerebral cortex.
Neurology 1987;37(6):916-22.
1987: Donald L Price; L C Cork; R G Struble; C A Kitt; Lary Walker; R E Powers; Peter J Whitehouse; John W Griffin
Dysfunction and death of neurons in human degenerative neurological diseases and in animal models.
Ciba Foundation symposium 1987;126():30-48.
1987: R E Powers; Lary Walker; E B DeSouza; W W Vale; R G Struble; Peter J Whitehouse; Donald L Price
Immunohistochemical study of neurons containing corticotropin-releasing factor in Alzheimer's disease.
Synapse (New York, N.Y.) 1987;1(5):405-10.
1987: E B De Souza; Peter J Whitehouse; Donald L Price; W W Vale
Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders.
Annals of the New York Academy of Sciences 1987;512():237-47.
1987: Peter J Whitehouse; K J Kellar
Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders.
Journal of neural transmission. Supplementum 1987;24():175-82.
1987: Peter J Whitehouse
Alzheimer's disease, a multisystem disorder: implications for therapy.
Psychopharmacology bulletin 1987;23(1):15-8.
1987: Peter J Whitehouse
Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
Advances in neurology 1987;45():393-7.
1987: Peter J Whitehouse
Neurotransmitter receptor alterations in Alzheimer disease: a review.
Alzheimer disease and associated disorders 1987;1(1):9-18.
1986: Arthur W Clark; Charles L White; H J Manz; I M Parhad; B Curry; Peter J Whitehouse; J Lehmann; J T Coyle
Primary degenerative dementia without Alzheimer pathology.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4 Suppl):462-70.
1986: R A Lyon; M Titeler; J James Frost; Peter J Whitehouse; Dean F Wong; Henry N Wagner; Robert F Dannals; Jonathan M Links; Michael J Kuhar
3H-3-N-methylspiperone labels D2 dopamine receptors in basal ganglia and S2 serotonin receptors in cerebral cortex.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1986;6(10):2941-9.
1986: George R. Uhl; G O Hackney; M Torchia; V Stranov; W W Tourtellotte; Peter J Whitehouse; V Tran; S Strittmatter
Parkinson's disease: nigral receptor changes support peptidergic role in nigrostriatal modulation.
Annals of neurology 1986;20(2):194-203.
1986: Peter J Whitehouse
Understanding the etiology of Alzheimer's disease. Current approaches.
Neurologic clinics 1986;4(2):427-37.
1986: Peter J Whitehouse; A M Martino; P G Antuono; P R Lowenstein; J T Coyle; Donald L Price; Kenneth J Kellar
Nicotinic acetylcholine binding sites in Alzheimer's disease.
Brain research 1986;371(1):146-51.
1986: E B De Souza; Peter J Whitehouse; Michael J Kuhar; Donald L Price; W W Vale
Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
Nature 1986;319(6054):593-5.
1986: Peter J Whitehouse; O Muramoto; Juan C Troncoso; I Kanazawa
Neurotransmitter receptors in olivopontocerebellar atrophy: an autoradiographic study.
Neurology 1986;36(2):193-7.
1986: Peter J Whitehouse; K S Au
Cholinergic receptors in aging and Alzheimer's disease.
Progress in neuro-psychopharmacology & biological psychiatry 1986;10(3-5):665-76.
1986: Donald L Price; R G Struble; Peter J Whitehouse; C A Kitt; L C Cork; Lary Walker; M F Casanova
Alzheimer's disease: a multisystem disorder.
Research publications - Association for Research in Nervous and Mental Disease 1986;64():209-14.
1986: Peter J Whitehouse
The concept of subcortical and cortical dementia: another look.
Annals of neurology 1986;19(1):1-6.
1985: M F Casanova; Lary Walker; Peter J Whitehouse; Donald L Price
Abnormalities of the nucleus basalis in Down's syndrome.
Annals of neurology 1985;18(3):310-3.
1985: Peter J Whitehouse; R R Trifiletti; B E Jones; Susan E Folstein; Donald L Price; Solomon H Snyder; Michael J Kuhar
Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.
Annals of neurology 1985;18(2):202-10.
1985: Mark L Batshaw; R C Wachtel; A W Deckel; Peter J Whitehouse; H Moses; L J Fochtman; R Eldridge
Munchausen's syndrome simulating torsion dystonia.
The New England journal of medicine 1985;312(22):1437-9.
1985: E B De Souza; M H Perrin; Peter J Whitehouse; J Rivier; W Vale; Michael J Kuhar
Corticotropin-releasing factor receptors in human pituitary gland: autoradiographic localization.
Neuroendocrinology 1985;40(5):419-22.
1985: Peter J Whitehouse; J K Wamsley; M A Zarbin; Donald L Price; Michael J Kuhar
Neurotransmitter receptors in amyotrophic lateral sclerosis: possible relationship to sparing of eye movements.
Annals of neurology 1985;17(5):518.
1985: Peter J Whitehouse
Theodor Meynert: foreshadowing modern concepts of neuropsychiatric pathophysiology.
Neurology 1985;35(3):389-91.
1985: Donald L Price; L C Cork; R G Struble; Peter J Whitehouse; C A Kitt; Lary Walker
The functional organization of the basal forebrain cholinergic system in primates and the role of this system in Alzheimer's disease.
Annals of the New York Academy of Sciences 1985;444():287-95.
1985: Peter J Whitehouse; R G Struble; J C Hedreen; A W Clark; Donald L Price
Alzheimer's disease and related dementias: selective involvement of specific neuronal systems.
CRC critical reviews in clinical neurobiology 1985;1(4):319-39.
1985: Donald L Price; C A Kitt; R G Struble; Peter J Whitehouse; L C Cork; Lary Walker
Neurobiological studies of transmitter systems in aging and in Alzheimer-type dementia.
Annals of the New York Academy of Sciences 1985;457():35-51.
1985: Donald L Price; Peter J Whitehouse; R G Struble
Alzheimer's disease.
Annual review of medicine 1985;36():349-56.
1984: George R. Uhl; Peter J Whitehouse; Donald L Price; W W Tourtelotte; Michael J Kuhar
Parkinson's disease: depletion of substantia nigra neurotensin receptors.
Brain research 1984;308(1):186-90.
1984: Peter J Whitehouse; D Lynch; Michael J Kuhar
Effects of postmortem delay and temperature on neurotransmitter receptor binding in a rat model of the human autopsy process.
Journal of neurochemistry 1984;43(2):553-9.
1984: J C Hedreen; R G Struble; Peter J Whitehouse; Donald L Price
Topography of the magnocellular basal forebrain system in human brain.
Journal of neuropathology and experimental neurology 1984;43(1):1-21.
1983: George R. Uhl; D C Hilt; J C Hedreen; Peter J Whitehouse; Donald L Price
Pick's disease (lobar sclerosis): depletion of neurons in the nucleus basalis of Meynert.
Neurology 1983;33(11):1470-3.
1983: MARSHAL FOLSTEIN; Peter J Whitehouse
Cognitive impairment of Alzheimer disease.
Neurobehavioral toxicology and teratology 1983;5(6):631-4.
1983: D L Niehoff; Peter J Whitehouse
Multiple benzodiazepine receptors: autoradiographic localization in normal human amygdala.
Brain research 1983;276(2):237-45.
1983: A W Clark; I M Parhad; Susan E Folstein; Peter J Whitehouse; J C Hedreen; Donald L Price; G A Chase
The nucleus basalis in Huntington's disease.
Neurology 1983;33(10):1262-7.
1983: Peter J Whitehouse; J K Wamsley; M A Zarbin; Donald L Price; W W Tourtellotte; Michael J Kuhar
Amyotrophic lateral sclerosis: alterations in neurotransmitter receptors.
Annals of neurology 1983;14(1):8-16.
1983: Peter J Whitehouse; J C Hedreen; Charles L White; Donald L Price
Basal forebrain neurons in the dementia of Parkinson disease.
Annals of neurology 1983;13(3):243-8.
1983: Peter J Whitehouse; R G Struble; J C Hedreen; A W Clark; Charles L White; I M Parhad; Donald L Price
Neuroanatomical evidence for a cholinergic deficit in Alzheimer's disease.
Psychopharmacology bulletin 1983;19(3):437-40.
1982: Peter J Whitehouse; R G Struble; A W Clark; Donald L Price
Alzheimer disease: plaques, tangles, and the basal forebrain.
Annals of neurology 1982;12(5):494.
1982: Peter J Whitehouse; M L Bleecker
Co-occurring ophthalmoplegia and hemiparesis in a case of migraine.
Archives of neurology 1982;39(7):445-6.
1982: R G Struble; L C Cork; Peter J Whitehouse; Donald L Price
Cholinergic innervation in neuritic plaques.
Science (New York, N.Y.) 1982;216(4544):413-5.
1982: Peter J Whitehouse; Donald L Price; R G Struble; A W Clark; J T Coyle; M R Delon
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.
Science (New York, N.Y.) 1982;215(4537):1237-9.
1982: Donald L Price; Peter J Whitehouse; R G Struble; J T Coyle; A W Clark; Mahlon R DeLong; L C Cork; J C Hedreen
Alzheimer's disease and Down's syndrome.
Annals of the New York Academy of Sciences 1982;396():145-64.
1981: N D LaFrance; Henry N Wagner; Peter J Whitehouse; E Corley; T Duelfer
Decreased accumulation of isopropyl-lodoamphetamine (I-123) in brain tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1981;22(12):1081-3.
1981: Peter J Whitehouse
Imagery and verbal encoding in left and right hemisphere damaged patients.
Brain and language 1981;14(2):315-32.
1981: Peter J Whitehouse; Donald L Price; A W Clark; J T Coyle; Mahlon R DeLong
Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.
Annals of neurology 1981;10(2):122-6.
1978: Peter J Whitehouse; A Caramazza; E Zurif
Naming in aphasia: interacting effects of form and function.
Brain and language 1978;6(1):63-74.